Literature DB >> 28385835

Genome Sequence of a Toxin-Positive Clostridium difficile Strain Isolated from Murine Feces.

Lucie Etienne-Mesmin1, Benoit Chassaing2, Oluwaseyi Adekunle3, Lisa M Mattei4, Adrianne N Edwards5, Shonna M McBride5, Frederic D Bushman6, Andrew T Gewirtz2.   

Abstract

Herein, we report the genome sequence of a Clostridium difficile strain isolated from the feces of antibiotic-treated C57BL/6 mice. We have named this strain, which differs considerably from those of the previously sequenced C. difficile strains, LEM1.
Copyright © 2017 Etienne-Mesmin et al.

Entities:  

Year:  2017        PMID: 28385835      PMCID: PMC5383883          DOI: 10.1128/genomeA.00088-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Clostridium difficile is a toxin-producing spore-forming bacterium representing the leading cause of nosocomial diseases in the United States (1, 2). C. difficile-induced disease is largely driven by the two exotoxins A (TcdA) and B (TcdB), which are part of a 19.6-kb pathogenicity locus (PaLoc), that contribute to diarrhea and severe colitis (3). Ablation of the gut microbiota with the use of antibiotics renders individuals susceptible to C. difficile infection (CDI) (4). In mice, CDI is modeled by antibiotherapy (antibiotic cocktail in drinking water ad libitum and intraperitoneal injection of clindamycin), followed by exposure to C. difficile spores (5). We have observed that following this treatment, a substantial percentage of antibiotic-treated C57BL/6 mice exhibited detectable levels of fecal C. difficile prior to infection (6). Fecal samples tested positive for C. difficile upon antibiotherapy were plated onto taurocholate-cefoxitin-cycloserine-fructose agar (7, 8) and incubated anaerobically (48 h, 37°C) (9). Isolates that exhibited the characteristic C. difficile colony morphologies were further isolated on brain heart infusion agar supplemented with yeast extract and subsequently tested PCR positive for the presence of the tcdB gene (data not shown). C. difficile spores were prepared as described by Edwards et al. (10). Genomic DNA was extracted from a pure spore preparation of C. difficile LEM1, according to the Pacific Biosciences phenol-chloroform protocol (PacBio), with the following modifications prior to DNA extraction: 10 min of incubation with 10% SDS (64°C), 3 min of bead beating with glass beads, and centrifugation (12,000 rpm, 5 min). DNA integrity was checked by agarose gel electrophoresis, and purity was verified by 260 and 280 nm optical density measurements on an Epoch BioTek instrument. Complete genome sequencing of C. difficile LEM1 was carried out using single-molecule real-time (SMRT) sequencing technology on a PacBio RSII (Pacific Biosciences, Menlo Park, CA). Each library was loaded on SMRT cells (SMRT Cells 8Pac version 3) and sequenced using C4 chemistry. Genome assembly was performed with the HGAP.2 protocol (SMRT Analysis 2.3.0). The resulting preassembled consensus sequences were quality trimmed and then passed to the Celera Assembler. The assembly was refined by aligning all reads back to the assembly using BLASR. Quiver was used to call highly accurate consensus sequences. The polished genome was annotated using the RAST pipeline (11). A single circularized chromosomal contig was generated, with 4,191,506 bp in length and a G+C content of 28.8%. C. difficile LEM1 contains 4,118 predicted coding DNA sequences and 123 RNA genes, among which 33 are rRNAs and 90 are tRNAs. Comparisons with the well-characterized C. difficile strain VPI 10463 revealed high sequence similarity (91 to 95%) but also unveiled unique sequences in the genome of C. difficile LEM1. Genome analysis of LEM1 PaLoc, based on established standards within the C. difficile field (12, 13), revealed that this strain is toxinotype 0, like VPI 10463. There are no differences in the TcdA and TcdB sequences themselves, nor in their respective promoters. In vivo and in vitro assays demonstrated that LEM1 produced a smaller amount of toxins than VPI 10463 (6). Multiple mobile elements related to phages were detected in the C. difficile LEM1 genome and may play a role in the pathogenesis of this strain.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession no. CP019469 for C. difficile LEM1 and MUJV00000000 for C. difficile VPI 10463. The versions described in this paper are versions CP019469.1 and MUJV01000000 (which consists of sequences MUJV01000001 to MUJV01000002) for LEM1 and VPI 10463, respectively.
  13 in total

Review 1.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

2.  Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile.

Authors:  Lucie Etienne-Mesmin; Benoit Chassaing; Oluwaseyi Adekunle; Lisa M Mattei; Frederic D Bushman; Andrew T Gewirtz
Journal:  Gut       Date:  2017-02-20       Impact factor: 23.059

3.  Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.

Authors:  Adrianne N Edwards; Kathryn L Nawrocki; Shonna M McBride
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

4.  Clostridium difficile toxinotyping.

Authors:  Maja Rupnik
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Breakthroughs in the treatment and prevention of Clostridium difficile infection.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-10       Impact factor: 46.802

6.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

7.  Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.

Authors:  K H Wilson; M J Kennedy; F R Fekety
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

8.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 9.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  1 in total

1.  IL-17-producing γδ T cells protect against Clostridium difficile infection.

Authors:  Yee-Shiuan Chen; Iuan-Bor Chen; Giang Pham; Tzu-Yu Shao; Hansraj Bangar; Sing Sing Way; David B Haslam
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.